Radiotheranostics in oncology: making precision medicine possible
EO Aboagye, TD Barwick… - CA: A Cancer Journal for …, 2023 - Wiley Online Library
A quintessential setting for precision medicine, theranostics refers to a rapidly evolving field
of medicine in which disease is diagnosed followed by treatment of disease‐positive …
of medicine in which disease is diagnosed followed by treatment of disease‐positive …
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
K Mortezaee - Life sciences, 2020 - Elsevier
Tumors are dynamic tissue masses, so requiring continuous exposure to the host cells,
nurturing them into pave a path for tumor growth and metastasis. CXC chemokine ligand 12 …
nurturing them into pave a path for tumor growth and metastasis. CXC chemokine ligand 12 …
PET imaging in patients with brain metastasis—report of the RANO/PET group
Brain metastases (BM) from extracranial cancer are associated with significant morbidity and
mortality. Effective local treatment options are stereotactic radiotherapy, including …
mortality. Effective local treatment options are stereotactic radiotherapy, including …
Design and challenges of radiopharmaceuticals
K Vermeulen, M Vandamme, G Bormans… - Seminars in nuclear …, 2019 - Elsevier
This review describes general concepts with regard to radiopharmaceuticals for diagnostic
or therapeutic applications that help to understand the specific challenges encountered …
or therapeutic applications that help to understand the specific challenges encountered …
[HTML][HTML] Targeting CXCR4 in AML and all
D Cancilla, MP Rettig, JF DiPersio - Frontiers in oncology, 2020 - frontiersin.org
The interaction of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as …
blasts with the bone marrow microenvironment regulates self-renewal, growth signaling, as …
Radiolabeled peptides and antibodies in medicine
P Kręcisz, K Czarnecka, L Królicki… - Bioconjugate …, 2020 - ACS Publications
Radiolabeled peptides are a relatively new, very specific radiotracer group, which is still
expanding. This group is very diverse in terms of peptide size. It contains very small …
expanding. This group is very diverse in terms of peptide size. It contains very small …
[HTML][HTML] Kirenol: a potential natural lead molecule for a new drug design, development, and therapy for inflammation
Kirenol, a potential natural diterpenoid molecule, is mainly found in Sigesbeckia species.
Kirenol has received a lot of interest in recent years due to its wide range of pharmacological …
Kirenol has received a lot of interest in recent years due to its wide range of pharmacological …
[PDF][PDF] The tumor microenvironment and immunotherapy in prostate and bladder cancer
Acknowledgements: The authors wish to thank Sima Rabinowitz, SR for editorial assistance.
The authors wish to acknowledge funding support from the Deane Prostate Health, ISMMS …
The authors wish to acknowledge funding support from the Deane Prostate Health, ISMMS …
Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET/CT
J Duell, F Krummenast, A Schirbel… - Journal of Nuclear …, 2021 - Soc Nuclear Med
PET/CT with 18F-FDG is an integral component in the primary staging of most lymphomas.
However, its utility is limited in marginal-zone lymphoma (MZL) because of inconsistent 18F …
However, its utility is limited in marginal-zone lymphoma (MZL) because of inconsistent 18F …
[HTML][HTML] Clinical advances and perspectives in targeted radionuclide therapy
N Lepareur, B Ramée, M Mougin-Degraef… - Pharmaceutics, 2023 - mdpi.com
Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …